verve-101
·Code: VERVE-101
verve-101: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Verve Therapeutics, Inc. (VERV) | Phase 1 |
Clinical Trials (1)
Open-label, Phase 1b, Single-ascending Dose and Optional re Dosing Study to Evaluate the Safety of VERVE-101 Administered to Patients With Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, and Uncontrolled Hypercholesterolemia
Frequently asked questions
Who is developing verve-101?
verve-101 is being developed by Verve Therapeutics, Inc..
How many clinical trials involve verve-101?
BioSniper tracks 1 clinical trial involving verve-101.
Get deeper analysis on verve-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis